INCB053914

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB053914, covering 2021-12-08 to 2021-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of INCB053914 in Subjects With Advanced Malignancies [Phase 1, Phase 2]